Related Experiment Video

Updated: Jun 30, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Preserved DNA from past clinical trials yields new information about a subtype of alcoholism

Charles P O'Brien

    Current Psychiatry Reports
    |September 23, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
    07:31

    Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

    Published on: January 7, 2019

    An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
    07:28

    An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

    Published on: April 15, 2015

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
    05:12

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

    Published on: June 23, 2023

    Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
    07:31

    Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

    Published on: January 7, 2019

    An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
    07:28

    An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

    Published on: April 15, 2015

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Effects of current smoking severity on brain gray matter volume in opioid use disorder - a voxel-based morphometry study.

    The American journal of drug and alcohol abuse·2023

    Multivariate pattern analysis links drug use severity to distributed cortical hypoactivity during emotional inhibitory control in opioid use disorder.

    NeuroImage. Clinical·2021

    The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder.

    Addiction biology·2020

    The Persistent Challenge of Developing Addiction Pharmacotherapies.

    Cold Spring Harbor perspectives in medicine·2020

    Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain.

    The journal of pain·2019

    Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.

    Drug and alcohol dependence·2018

    Recent Evidence on Factors and Potential Interventions Affecting Patient Sleep in Inpatient and Hospital Settings.

    Current psychiatry reports·2026

    Considering Autism in Binge-Type Eating Disorders: Broadening Beyond an Anorexia Nervosa-Focused Model.

    Current psychiatry reports·2026

    Psychological Autopsy Protocols - A Selective Narrative Review.

    Current psychiatry reports·2026

    The School-to-Guardian Pipeline: Understanding the Medical and Social Implications for Individuals with Significant Disabilities.

    Current psychiatry reports·2026

    Integrating Yoga and Mindfulness in the Management of Internet Gaming Disorder: A Narrative Review of Current Evidence and Future Directions.

    Current psychiatry reports·2026

    Associations Between Different Subtypes of Adverse Childhood Experiences with Reproductive Mood Disorders-a Scoping Review.

    Current psychiatry reports·2026

    Leveraging Natural Language Processing to Identify Variation in Kidney Transplant Access.

    Kidney international reports·2026

    Redundancy in the DSM-5 substance use disorder criterion set: Evidence from a national U.S. survey.

    Psychological assessment·2026

    Spine Centers in Northeastern United States: Assessing Similarities and Disparities to Build more Homogeneity Across the Country.

    Current pain and headache reports·2026

    Persistent kidney dysfunction after leptospirosis-associated acute kidney injury: a case series from coastal Karnataka, India.

    International urology and nephrology·2026

    Convulsions, Palsy, and the Spanish Inquisition: Neurologic Cases in an Overlooked Historical Archive.

    Neurology·2026

    Impact of Texas's Electronic Sexual Assault Evidence Kit Tracking System on Emergency Department Utilization for Sexual Assault Care.

    American journal of public health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us